Travere Therapeutics, Inc. (TVTX)
44.76
-0.04
(-0.09%)
USD |
NASDAQ |
May 06, 16:00
44.76
0.00 (0.00%)
Pre-Market: 08:25
Travere Therapeutics Free Cash Flow : -28.94M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ligand Pharmaceuticals, Inc. | 38.04M |
| Revolution Medicines, Inc. | -913.73M |
| ICU Medical, Inc. | 82.83M |
| Tandem Diabetes Care, Inc. | -29.67M |
| iRhythm Holdings, Inc. | 18.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.37M |
| Cash from Investing (Quarterly) | 21.55M |
| Cash from Financing (Quarterly) | 4.204M |
| Free Cash Flow Per Share (Quarterly) | -0.6808 |
| Free Cash Flow to Equity (Quarterly) | -61.47M |
| Free Cash Flow to Firm (Quarterly) | -60.25M |
| Free Cash Flow Yield | -0.69% |